Future research should examine how sulfonylurea-induced ABC transporter modulation affects drug bioavailability, BBB function, and -amyloid clearance, potentially influencing AD risk in DM2 patients
For any questions or concerns about your health or medications, please consult your physician or healthcare provider
This point is effectively made in a recently conducted large trial, which states that, our understanding of the mechanisms of cardiovascular protection with [the GLP-1 agonist] semaglutide remains speculativeclinical benefit is [thought to be] achieved through multiple interrelated pathways. Acknowledgement of this evidence gap prompted our lab, through use of a large animal model of CAD that replicates the features of disease as it occurs in humans, to investigate the cardiac consequences of semaglutide administration
Our experts can help
This can cause pain, numbness, and other complications that may require medical attention
doi: 10.1016/j.bcp.2022.115384 274 HiguchiSOhtsuHSuzukiHShiraiHFrankGDEguchiS